trending Market Intelligence /marketintelligence/en/news-insights/trending/ck_sxzozgnl9obceuzbz7q2 content esgSubNav
In This List

Scythian Biosciences extends letter of intent to buy medical cannabis company

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Scythian Biosciences extends letter of intent to buy medical cannabis company

Scythian Biosciences Corp. said it extended the previously announced letter of intent to buy MMJ International Investments Inc., a company pursuing medical cannabis opportunities in South America.

The companies now have until April 30 to negotiate a definitive deal, as opposed to March 31 previously.

Scythian, a Canadian medical cannabis company, added that its COO David Schrader will step down on March 31.